Our Pricing

Get Mounjaro Weight Loss Treatment with Code WEIGHTLOSSNEW

Published on: June 03, 2026

Searching for mounjaro weight loss treatment uk discount code options? At Cured Pharmacy, you can access genuine UK-licensed Mounjaro (tirzepatide) injections from £124.99 with transparent upfront pricing, free clinical consultation by UK prescribers, and discreet next-day delivery. Our code WEIGHTLOSSNEW gives you access to competitive pricing on this breakthrough dual-action weight loss treatment.

How Mounjaro Weight Loss Treatment Works in the UK

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed by the MHRA for weight management in the UK [1]. Unlike older single-pathway treatments such as semaglutide, tirzepatide activates two natural hormone receptors simultaneously — glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) — which work together to regulate appetite, slow gastric emptying, and improve insulin sensitivity.

In the landmark SURMOUNT-1 trial, participants receiving the highest maintenance dose of tirzepatide (15mg weekly) achieved an average body weight reduction of 22.5% over 72 weeks, compared to 2.4% with placebo [1]. This represents one of the most significant weight loss outcomes observed in clinical trials for any pharmacological intervention. The dual-action mechanism appears to produce greater metabolic benefits than single-pathway GLP-1 agonists, with superior improvements in glycaemic control and cardiovascular risk markers [2].

Mounjaro is administered once weekly via a pre-filled KwikPen injection device, designed for subcutaneous self-administration in the abdomen, thigh, or upper arm. Treatment typically begins at a lower starter dose (2.5mg) and is gradually titrated upward every four weeks, allowing your body to adjust and minimising gastrointestinal side effects. Your UK prescriber will determine the optimal maintenance dose based on your response and tolerability, subject to ongoing clinical assessment.

Mounjaro Discount Code UK: Understanding Your Pricing Options

At Cured Pharmacy, Mounjaro weight loss injections start from £124.99 representing competitive pricing compared to typical UK market rates. Unlike some online pharmacies that hide costs until after consultation, we display transparent upfront pricing so you can make informed decisions before beginning your clinical assessment. Our code WEIGHTLOSSNEW provides access to these rates for new patients starting their weight management journey.

The final cost depends on your prescribed maintenance dose, which your UK prescriber determines based on your clinical response, weight loss goals, and tolerability. Mounjaro is available in six dosage strengths (2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, and 15mg), with treatment typically progressing through a structured titration schedule over several months. All Mounjaro prescriptions at Cured Pharmacy are dispensed by our UK-registered pharmacy team (GPhC 9012511) under the supervision of Superintendent Pharmacist Tarun Kumar (GPhC 2233073).

It's important to note that Mounjaro is not currently available on NHS prescription for weight management in most areas of the UK, meaning private prescription is the primary access route for eligible patients. As a prescription-only medicine, Mounjaro requires clinical assessment by a UK-registered prescriber before it can be legally supplied — no legitimate UK pharmacy can dispense it without a valid prescription.

What's Included in Your Mounjaro Treatment Package

Your Mounjaro prescription from Cured Pharmacy includes free online consultation with a UK prescriber (completed in under 3 minutes), genuine UK-licensed medication sourced directly from licensed wholesalers, discreet packaging with no external branding, and next-day delivery to your chosen address. We also provide ongoing clinical support throughout your treatment, with regular follow-up assessments to monitor your progress and adjust your prescription as needed.

Mounjaro vs Wegovy: Comparing Weight Loss Injection Options

Both Mounjaro (tirzepatide) and Wegovy (semaglutide) are injectable weight loss treatments licensed by the MHRA in the UK, but they work through different pharmacological mechanisms. Wegovy activates only the GLP-1 receptor pathway, while Mounjaro's dual GIP/GLP-1 action appears to produce greater average weight loss in head-to-head comparisons [3]. In clinical trials, tirzepatide demonstrated superior efficacy, with participants achieving approximately 6-8 percentage points greater body weight reduction compared to semaglutide at comparable timepoints [3].

Wegovy is priced from £135.00 at Cured Pharmacy, making it a more accessible option for some patients, though individual suitability depends on your medical history, previous treatment response, and clinical goals. Both medications require once-weekly subcutaneous injection and follow similar titration schedules to minimise side effects. Common adverse effects for both treatments include nausea, diarrhoea, constipation, and reduced appetite — typically most pronounced during dose escalation phases.

Your UK prescriber will assess which treatment aligns best with your clinical profile during your online consultation. Factors considered include your BMI, presence of weight-related comorbidities (such as type 2 diabetes, hypertension, or obstructive sleep apnoea), previous experience with GLP-1 medications, and contraindications such as personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Alternative Weight Loss Treatments Available

Beyond injectable GLP-1 treatments, Cured Pharmacy offers several alternative weight management options. Saxenda (liraglutide) is a daily injectable GLP-1 agonist priced from £135.00 suitable for patients who prefer more frequent dosing with potentially faster dose adjustments. Orlistat-based treatments (including branded Xenical, Alli, and generic Orlistat) work through a different mechanism by blocking fat absorption in the digestive system, with prices starting from £135.00. Mysimba combines naltrexone and bupropion to reduce appetite and cravings through central nervous system pathways, available from £135.00. Each treatment has distinct eligibility criteria, side effect profiles, and efficacy data — your prescriber will recommend the most appropriate option based on your individual circumstances.

Who Can Use Mounjaro Weight Loss Treatment in the UK

Mounjaro is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater in the presence of at least one weight-related comorbidity such as hypertension, type 2 diabetes, dyslipidaemia, or obstructive sleep apnoea [4]. The medication is intended as an adjunct to a reduced-calorie diet and increased physical activity, not as a standalone solution. Clinical guidelines emphasise that pharmacological weight management works most effectively when combined with comprehensive lifestyle modification programmes [4].

Mounjaro is contraindicated in patients with personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, or hypersensitivity to tirzepatide or any excipients. It should not be used during pregnancy or breastfeeding, and women of childbearing potential should use effective contraception during treatment. Caution is advised in patients with severe gastrointestinal disease, history of pancreatitis, or severe renal impairment, as these conditions may increase the risk of adverse effects or require dose adjustments.

During your free online consultation at Cured Pharmacy, our UK prescribers will review your complete medical history, current medications, and weight loss goals to determine if Mounjaro is clinically appropriate for you. This assessment typically takes under 3 minutes to complete and includes questions about previous weight loss attempts, existing health conditions, and any contraindications. If Mounjaro is not suitable, your prescriber may recommend alternative treatments from our weight management range, ensuring you receive the most appropriate care for your individual needs.

How to Start Mounjaro Treatment with Code WEIGHTLOSSNEW

Starting your Mounjaro weight loss journey at Cured Pharmacy is straightforward and can be completed entirely online. Begin by clicking 'Start Assessment' on our Mounjaro product page, which initiates a secure online consultation with one of our UK-registered prescribers. The consultation form asks about your weight history, current BMI, existing medical conditions, medications you're taking, and any previous experience with weight loss treatments. This process is designed to be completed in under 3 minutes while ensuring comprehensive clinical assessment.

Once submitted, your consultation is reviewed by a qualified UK prescriber, typically within 24 hours on weekdays. If Mounjaro is deemed clinically appropriate and you meet the eligibility criteria, your prescription is issued electronically and sent directly to our dispensing pharmacy team. We then prepare your medication using genuine UK-licensed Mounjaro KwikPens sourced from authorised wholesalers, package it discreetly with no external branding, and dispatch it via next-day courier to your preferred delivery address.

Your first prescription will include detailed patient information leaflets, injection technique guidance, and instructions for the dose titration schedule. Most patients begin with the 2.5mg starter dose for the first four weeks, progressing to 5mg, then potentially to higher maintenance doses (7.5mg, 10mg, 12.5mg, or 15mg) based on clinical response and tolerability. Regular follow-up consultations are required to monitor your progress, assess for adverse effects, and adjust your prescription as needed — these ongoing assessments ensure safe, effective treatment throughout your weight management programme.

What to Expect During Your First Month

During the initial 2.5mg starter phase, many patients experience mild gastrointestinal symptoms such as nausea, reduced appetite, or changes in bowel habits as their body adjusts to the medication [1]. These effects typically diminish over the first few weeks and can be minimised by eating smaller portions, avoiding high-fat meals, and staying well-hydrated. Weight loss during the first month is often modest (1-3 kg on average), with more significant reductions occurring as the dose is titrated upward in subsequent months. Your UK prescriber will provide personalised advice on managing side effects and optimising your treatment response during follow-up consultations.

Mounjaro Safety Profile and Common Side Effects

The most frequently reported side effects of Mounjaro in clinical trials were gastrointestinal in nature, including nausea (experienced by 20-30% of participants), diarrhoea, vomiting, constipation, and abdominal discomfort [1]. These effects were generally mild to moderate in severity, most common during dose escalation phases, and tended to resolve within a few weeks as patients adapted to the medication. Serious adverse events were rare but included pancreatitis, gallbladder disease, and severe hypoglycaemia (primarily in patients also taking insulin or sulfonylureas).

Tirzepatide carries a boxed warning in its prescribing information regarding thyroid C-cell tumours observed in rodent studies, though the relevance to humans remains uncertain [4]. As a precautionary measure, Mounjaro is contraindicated in patients with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2. Patients should be counselled to report symptoms such as a lump in the neck, persistent hoarseness, difficulty swallowing, or shortness of breath, which may indicate thyroid pathology requiring further investigation.

At Cured Pharmacy, patient safety is our highest priority. Our UK prescribers conduct thorough medical assessments before prescribing Mounjaro, and we provide ongoing clinical monitoring throughout your treatment. If you experience concerning symptoms such as severe abdominal pain (potentially indicating pancreatitis), persistent vomiting leading to dehydration, changes in vision, or signs of allergic reaction, you should stop the medication and seek immediate medical attention. Our pharmacy team is available on (+44) 116 4646009 during business hours to address any concerns about your treatment.

Drug Interactions and Special Precautions

Mounjaro may slow gastric emptying, which can affect the absorption of oral medications taken concurrently. This is particularly relevant for medications with narrow therapeutic windows or those requiring rapid absorption, such as oral contraceptives or antibiotics. Your prescriber will review all your current medications during consultation to identify potential interactions and provide guidance on timing of administration if needed. Patients with type 2 diabetes taking insulin or sulfonylureas may require dose adjustments to prevent hypoglycaemia, as tirzepatide improves glycaemic control and can potentiate the glucose-lowering effects of these medications.

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., Wharton, S., Connery, L., Alves, B., Kiyosue, A., Zhang, S., Liu, B., Bunck, M. C., Stefanski, A., & SURMOUNT-1 Investigators. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038 [accessed 13 August 2026]
2. Frías, J. P., Davies, M. J., Rosenstock, J., Pérez Manghi, F. C., Fernández Landó, L., Bergman, B. K., Liu, B., Cui, X., Brown, K. D., SURPASS-2 Investigators. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519 [accessed 13 August 2026]
3. Rosenstock, J., Wysham, C., Frías, J. P., Kaneko, S., Lee, C. J., Fernández Landó, L., Mao, H., Cui, X., Karanikas, C. A., & Thieu, V. T. (2021). Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. The Lancet, 398(10295), 143–155. https://doi.org/10.1016/S0140-6736(21)01324-6 [accessed 13 August 2026]
4. Medicines and Healthcare products Regulatory Agency. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen - Summary of Product Characteristics. Electronic Medicines Compendium. Retrieved from https://www.medicines.org.uk/emc/product/14913 [accessed 13 August 2026]
5. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 13 August 2026.
6. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 13 August 2026.
7. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 13 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Weight loss results vary between individuals and depend on adherence to treatment, dietary modifications, and physical activity levels. Past clinical trial results do not guarantee individual outcomes.